DIANTHUS THERAPEUTICS INC
DNTH · NASDAQ
Updated at 2026-10-13 15:28:33
- Today's High
- $81.47
- Today’s Low
- $79.32
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $81.77
- Previous Close
- $81.57
- Volume
- 853.94K
- Market Cap
- $4.56B
- P/E Ratio
- --
- EPS
- $-4.14
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 7 TIMES SQUARE, NEW YORK, NY, UNITED STATES, 10036
- Country
- US
- Listing Date
- 2018-06-21
- Fiscal Year End
- December
- Shares Outstanding
- 54.67M
- CIK
- 0001690585
- Website
- dianthustx.com
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops, and delivers novel monoclonal antibodies for people living with severe autoimmune and inflammatory diseases. The company is headquartered in New York, New York.
Financial Metrics
Revenue
2026-06-30
$761K
2026-03-31
$463K
2025-12-31
$284K
2025-09-30
$396K
Operating Expenses
2026-06-30
$62.24M
2026-03-31
$46.92M
2025-12-31
$69.82M
2025-09-30
$40.68M
Net Income
2026-06-30
-$50.21M
2026-03-31
-$40.83M
2025-12-31
$97.9M
2025-09-30
-$36.76M
Net Profit Margin
2026-06-30
-6.59K%
2026-03-31
-8.81K%
2025-12-31
34.47K%
2025-09-30
-9.28K%
Earnings Per Share
2026-06-30
$-0.90
2026-03-31
$-0.85
2025-12-31
$-1.43
2025-09-30
$-0.97
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$50.1M
2026-03-31
-$40.75M
2025-12-31
$98M
2025-09-30
-$36.66M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $761K | $463K | $284K | $396K |
| Operating Expenses | $62.24M | $46.92M | $69.82M | $40.68M |
| Net Income | -$50.21M | -$40.83M | $97.9M | -$36.76M |
| Net Profit Margin | -6.59K% | -8.81K% | 34.47K% | -9.28K% |
| Earnings Per Share | $-0.90 | $-0.85 | $-1.43 | $-0.97 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$50.1M | -$40.75M | $98M | -$36.66M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.